Ascent Pediatrics

Wilmington, United States Founded: 1989 • Age: 37 yrs Listed Acquired By Medicis Pharmaceutical
Approved drugs are reformulated for common pediatric illnesses.

About Ascent Pediatrics

Ascent Pediatrics is a Healthcare company based in Wilmington (United States) founded in 1989, and was acquired by Medicis Pharmaceutical in October 2001. Approved drugs are reformulated for common pediatric illnesses. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.

Company details

Ascent Pediatrics was founded in 1989 in Wilmington, United States, and operated in the pharmaceutical sector with a focus on pediatrics. Proprietary drug delivery and reformulation technologies were applied to develop improved pharmaceuticals for common childhood illnesses. The companys efforts targeted enhancements to existing products. Operations ceased following a merger with Medicis Pharmaceuticals in November 2001.

Key Metrics

Funding Insights of Ascent Pediatrics

  • Total Rounds 1
  • Last Round Post-IPO β€” $16M
  • First Round $16M

    (Jun 1998)

All 1 funding rounds of Ascent Pediatrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 1998$16MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Ascent Pediatrics

Ascent Pediatrics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medicis Pharmaceutical.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Specialty pharmaceuticals for dermatological conditions are developed and marketed.
1988medicis.comScottsdale, United States
Premium access

Investor details for Ascent Pediatrics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Ascent Pediatrics

4 dated milestones of Ascent Pediatrics across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ascent Pediatrics is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $16.0M.
  4. Exit Acquired by Medicis Pharmaceutical.

Competitors of Ascent Pediatrics

Ascent Pediatrics has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
Premium access

Detailed competitors of Ascent Pediatrics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Ascent Pediatrics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ascent Pediatrics

Ascent Pediatrics was founded in 1989 and raised its 1st funding round 9 years after it was founded.

Ascent Pediatrics is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

Ascent Pediatrics was founded in 1989 in Wilmington, United States, and operated in the pharmaceutical sector with a focus on pediatrics. Proprietary drug delivery and reformulation technologies were applied to develop improved pharmaceuticals for common childhood illnesses. The companys efforts targeted enhancements to existing products. Operations ceased following a merger with Medicis Pharmaceuticals in November 2001.

Ascent Pediatrics's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.

Ascent Pediatrics has 1 investor. Key investors include Medicis Pharmaceutical.

Yes. Ascent Pediatrics was acquired by Medicis Pharmaceutical in October 2001.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available